Key statistics
On Friday, Enovis Corp (0I1B:LSE) closed at 46.90, 21.65% above the 52 week low of 38.55 set on Oct 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 46.90 |
Low | 46.90 |
Bid | -- |
Offer | -- |
Previous close | 45.88 |
Average volume | 48.30k |
---|---|
Shares outstanding | 55.88m |
Free float | 55.34m |
P/E (TTM) | -- |
Market cap | 2.58bn USD |
EPS (TTM) | -2.21 USD |
Data delayed at least 20 minutes, as of Nov 22 2024 15:01 GMT.
More ▼
Announcements
- Enovis to Participate in Upcoming Investor Conferences
- Enovis Announces Third Quarter 2024 Results
- Enovis to Host Third Quarter 2024 Results Conference Call on November 6th
- Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies
- Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting
- Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures
- Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability
- Enovis Announces Second Quarter 2024 Results
- Enovis Announces Time Change for Second Quarter 2024 Results Conference Call
- Enovis to Host Second Quarter 2024 Results Conference Call on August 7th
More ▼